NCT00504543 - Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients | Biotech Hunter

Enrollment

311

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions

Kidney Transplantation

Interventions

DRUG

AEB071

oral, twice daily

DRUG

Certican

twice daily

DRUG

Neoral

twice daily

Trial Locations (26)

1090

Austria, Wein

1107

Argentina, Buenos Aires

1425

Novartis Investigative Site, Buenos Aires

2050

Australia, Sydney

5011

Australia, Sydney

6020

Austria, Innsbruck

8091

Novartis Investigative Site, Zurich

9000

Belgium, Ghent

10002

Novartis Investigative Site, Taipie

10117

Novartis Investigative Site, Berlin

14021

Czech Republic, Prague

20100

Italy, Milan

20122

Italy, Milan

28034

Spain, Madrid

31055

France, Toulouse

59037

France, Lille

69120

Novartis Investigative Site, Heidelberg

97517

Novartis Investigative Site, Banská Bystrica

119074

Novartis Investigative Site, Singapore

04038-002

Brazil, São Paulo

Unknown

Novartis Investigative Site, Bogotá

Novartis Investigative Site, Santiago de Cali

3000CA

Netherlands, Rotterdam

0027

Norway, Oslo

04066

Novartis Investigative Site, Košice

08024

Spain, Barcelona